CAMP4 Therapeutics (CAMP)
3.96
+0.06 (1.54%)
Upcoming Events
Latest Headlines
Camp4 Therapeutics gets EU approval for SYNGAP1 disorder trial
October 27, 2026 8:00 AM - StreetInsider
CAMP4 Therapeutics Receives Clinical Trial Application Approval for Phase 1/2 Clinical Trial of CMP-002 in Patients with SYNGAP1-Related Disorder in the European Union
October 27, 2026 8:00 AM - StreetInsider
Raymond James Starts CAMP4 Therapeutics Corp (CAMP) at Strong Buy
October 23, 2026 6:07 AM - StreetInsider
Needham Starts CAMP4 Therapeutics Corp (CAMP) at Buy
October 15, 2026 5:23 AM - StreetInsider
CAMP4 to Participate in Chardan’s 10th Annual Healthcare Conference
October 14, 2026 8:00 AM - StreetInsider
Oppenheimer Starts CAMP4 Therapeutics Corp (CAMP) at Outperform
October 5, 2026 6:58 AM - StreetInsider
CAMP4 Therapeutics (CAMP) Reiterated at Overweight by Cantor Fitzgerald After Analyst Day
September 29, 2026 7:18 AM - StreetInsider
CAMP4 Therapeutics Corp (CAMP) PT Lowered to $6 at Chardan
September 29, 2026 6:10 AM - StreetInsider
Camp4 Therapeutics gets UK approval for SYNGAP1 drug trial
September 10, 2026 7:33 AM - StreetInsider
CAMP4 Therapeutics Receives Authorization in the United Kingdom for Phase 1/2 Human Clinical Trial of CMP-002 in Patients with SYNGAP1-Related Disorder
September 10, 2026 7:33 AM - Globe NewsWire
CAMP4 Therapeutics to Host Virtual Analyst Day to Discuss CMP-002 for the Treatment of SYNGAP1-Related Disorder on September 28, 2026
September 8, 2026 4:05 PM - StreetInsider
CAMP4 to Participate in Upcoming Investor Conferences
September 1, 2026 4:05 PM - StreetInsider
Form 4 Camp4 Therapeutics Corp For: Aug 24 Filed by: Schwab Andrew J.
August 26, 2026 4:58 PM - SEC Filing
Form 4 Camp4 Therapeutics Corp For: Aug 19 Filed by: Schwab Andrew J.
August 21, 2026 4:59 PM - SEC Filing
Form 4 Camp4 Therapeutics Corp For: Aug 19 Filed by: Tardiff Daniel
August 19, 2026 8:46 PM - SEC Filing
CAMP4 Therapeutics Corp (CAMP) PT Raised to $15 at Piper Sandler
August 14, 2026 8:26 AM - StreetInsider
Calamp Corp. (CAMP) Misses Q2 EPS by 33c
August 14, 2026 5:51 AM - StreetInsider
CAMP4 Reports Second Quarter 2026 Financial Results and Corporate Highlights
August 13, 2026 4:05 PM - StreetInsider
Form 4 Camp4 Therapeutics Corp For: Aug 03 Filed by: 5AM Ventures VII, L.P.
August 5, 2026 5:40 PM - SEC Filing
Form 4 Camp4 Therapeutics Corp For: Aug 03 Filed by: Schwab Andrew J.
August 5, 2026 5:29 PM - SEC Filing
Form 4 Camp4 Therapeutics Corp For: Aug 03 Filed by: Young Richard A
August 5, 2026 5:10 PM - SEC Filing
Form 4 Camp4 Therapeutics Corp For: Aug 03 Filed by: Maricich Yuri
August 5, 2026 5:09 PM - SEC Filing
Form 4 Camp4 Therapeutics Corp For: Aug 03 Filed by: Gold Kelly
August 5, 2026 5:08 PM - SEC Filing
Form 4 Camp4 Therapeutics Corp For: Aug 03 Filed by: Mandel-Brehm Josh
August 5, 2026 5:07 PM - SEC Filing
Camp4 Therapeutics closes second tranche of $100M private placement
August 4, 2026 7:00 AM - StreetInsider
CAMP4 Therapeutics Announces Second Closing of $100 Million Private Placement
August 4, 2026 7:00 AM - StreetInsider
Full Article List
